glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare](https://hips.hearstapps.com/hmg-prod/images/8b89e94a-dad2-454f-a45f-3ed3b6be1419.png?crop=0.888888888889xw:1xh;center,top&resize=1200:*)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare](https://xtalks.com/wp-content/uploads/2025/03/Petrelintide-1024x576.png)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare](https://imgproxy.divecdn.com/Uen3WaSRQrS4Q4Ruldy39jm7wp7yZKOh-bFeEbuMcFE/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTUwMDMzMjU3LmpwZw==.webp)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare](https://preview.redd.it/roche-announces-positive-topline-results-from-phase-ii-v0-ex33warfcyfg1.png?width=955&format=png&auto=webp&s=5f77a02e3b4b4e2f12fee581b5b631d47613f779)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare](https://image.cnbcfm.com/api/v1/image/108007934-17212541051721254101-35407503975-1080pnbcnews.jpg?v=1721254103)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity glp 1 roche Best Skincare](https://cdn.sanity.io/images/0vv8moc6/act/a2600e19542c06929ee293856a50ee83e56612ad-5184x3456.jpg)









:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)















